DEANNA THOMAS: Open Payments
NPI 1669719928 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 49 payments from 11 companies in 2025. Trend: 2023 $69 · 2024 $32 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $193 |
| Novo Nordisk Inc | 14 | $140 |
| Lilly USA, LLC | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Amgen Inc. | 2 | $32 |
| Seqirus USA Inc | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: VRAYLAR, Ozempic, UBRELVY, Kerendia, Rybelsus, EVENITY, KISUNLA, MOUNJARO.
Industry payments across AL — which companies pay providers there.
